MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 24, 2018--
Intersect ENT, Inc. (Nasdaq: XENT)
today announced that management will be presenting at the 7th Annual
LEERINK Partners Global Healthcare Conference on Wednesday, February 14,
2018 at 2:30 p.m. ET at the Lotte New York Palace Hotel.
A live webcast of the presentation will be available online from the
Investor Relations page of the company's website at www.IntersectENT.com.
The webcast replay will be available for approximately one month.
About Intersect ENT®
Intersect ENT is dedicated to transforming ear, nose and throat care by
providing innovative, clinically meaningful therapies to physicians and
patients. The company’s steroid releasing implants are designed to
provide mechanical spacing and deliver targeted therapy to the site of
disease. In addition, Intersect ENT is continuing to expand its
portfolio of products based on the company’s unique localized steroid
releasing technology and is committed to broadening patient access to
less invasive and more cost-effective care.
For additional information on the company or the products including
risks and benefits please visit www.IntersectENT.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180124005753/en/
Source: Intersect ENT, Inc.
Intersect ENT, Inc.
Jeri Hilleman, 650-641-2105